TJ Biotech v. AgroSource: Voluntary Dismissal in Antimicrobial Plant Patent Appeal
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | TJ Biotech, LLC v. AgroSource, Inc. |
| Case Number | 26-1204 (Fed. Cir.) |
| Court | Federal Circuit, Appeal from District of Columbia |
| Duration | Nov 2025 – Feb 2026 71 days |
| Outcome | Voluntary Dismissal |
| Patents at Issue | |
| Accused Products | AgroSource’s Antimicrobial Plant Disease Products |
Case Overview
The Parties
⚖️ Plaintiff
The patent-holding plaintiff asserting rights over antimicrobial compositions designed for plant disease treatment — a high-value segment within agricultural biotechnology.
🛡️ Defendant
A company operating in the agrochemical and plant protection product space, whose commercial product line was accused of infringing TJ Biotech’s patent claims.
Patents at Issue
This case centered on a key patent covering antimicrobial compositions and methods for treating plant diseases, a high-value segment within agricultural biotechnology. Utility patents like this protect functional inventions related to specific compositions and their applications.
- • US12382956B2 — Antimicrobial compositions and methods for treating plant diseases
Developing a new plant protection product?
Check if your formulation might infringe this or related patents before launch.
The Verdict & Legal Analysis
Outcome
The Federal Circuit dismissed Case No. 26-1204 pursuant to a joint stipulation of voluntary dismissal under Federal Rule of Appellate Procedure 42(b), with each side bearing its own costs. No damages award, royalty determination, or injunctive relief was entered by the appellate court. The dismissal is non-precedential and leaves no binding claim construction or validity ruling on the record.
Key Legal Issues
The voluntary dismissal with each party bearing its own costs is a hallmark of a negotiated resolution, most commonly a settlement or licensing agreement reached outside of litigation. Resolution at the appellate stage avoided further legal costs and eliminated the risk of an unfavorable Federal Circuit ruling on claim scope or validity. This strategic move means the case produced no precedential ruling on the merits, but it underscores the active enforcement of US12382956B2 in the agricultural biotechnology sector.
Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in antimicrobial plant disease technology. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View active litigation and enforcement patterns
- See which companies are most active in plant disease patents
- Understand claim construction trends in agrochemical IP
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Antimicrobial plant disease compositions
1 Patent Actively Litigated
In this technology space
Design-Around Options
Strategic alternatives available
✅ Key Takeaways
Voluntary dismissal under FRCP 42(b) at the Federal Circuit stage is a recognized settlement mechanism that avoids binding adverse precedent.
Search related case law →US12382956B2 has been actively litigated — monitor for reactivation or related assertion campaigns.
Explore precedents →Mutual cost-bearing signals balanced negotiated resolution; assess implications for licensing terms in analogous disputes.
Analyze licensing agreements →Frequently Asked Questions
The case involved U.S. Patent No. US12382956B2 (Application No. US17/516229), covering antimicrobial compositions and methods for treating plant diseases.
The appeal was dismissed pursuant to a joint stipulation of voluntary dismissal under Federal Rule of Appellate Procedure 42(b), with each party bearing its own costs — consistent with an out-of-court settlement or commercial resolution.
The non-precedential dismissal leaves no binding ruling on US12382956B2’s validity or infringement scope, meaning the patent remains an active enforcement risk for competitors in the plant disease management market.
Ready to Strengthen Your Patent Strategy?
Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.
References
- United States Court of Appeals for the Federal Circuit — Case No. 26-1204
- Cornell Legal Information Institute — Federal Rule of Appellate Procedure 42(b)
- U.S. Patent and Trademark Office — Patent Resources
- PACER (Public Access to Court Electronic Records)
- PatSnap — IP Intelligence Solutions for Law Firms
This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.